scholarly journals Arthroscopic Management of Synovial Chondromatosis of the Temporomandibular Joint. Case Series and Systematic Review

2018 ◽  
Vol 17 (4) ◽  
pp. 401-409 ◽  
Author(s):  
Philip James Brabyn ◽  
Ana Capote ◽  
Mario Fernando Muñoz-Guerra ◽  
Ian Zylberberg ◽  
Francisco J. Rodríguez-Campo ◽  
...  
Keyword(s):  
Systematic Review ◽  
Temporomandibular Joint ◽  
Case Series ◽  
Synovial Chondromatosis ◽  
Arthroscopic Management

Pigmented villonodular synovitis of the temporomandibular joint with intracranial extension: A case series and systematic review

Head & Neck ◽  
2014 ◽  
Vol 37 (8) ◽  
pp. 1213-1224 ◽  
Author(s):  
Michael Safaee ◽  
Taemin Oh ◽  
Matthew Z. Sun ◽  
Andrew T. Parsa ◽  
Michael W. McDermott ◽  
...  
Keyword(s):  
Systematic Review ◽  
Temporomandibular Joint ◽  
Case Series ◽  
Pigmented Villonodular Synovitis ◽  
Intracranial Extension ◽  
Villonodular Synovitis ◽  
Pigmented Villonodular

scholarly journals Arthroscopic Management for Bipartite Patella: A Systematic Review

2021 ◽  
Vol 9 (8) ◽  
pp. 232596712110222
Author(s):  
Allison Loewen ◽  
Susan M. Ge ◽  
Yousef Marwan ◽  
Mark Burman ◽  
Paul A. Martineau
Keyword(s):  
Systematic Review ◽  
Journal Article ◽  
Case Series ◽  
Arthroscopic Treatment ◽  
Lateral Release ◽  
Return To Sports ◽  
Postoperative Rehabilitation ◽  
Arthroscopic Management ◽  
Bipartite Patella ◽  
Arthroscopic Excision

Background: Bipartite patella is a rare congenital condition that becomes painful following direct trauma or an overuse injury. If it remains painful despite nonoperative treatment, surgery may be warranted. The current gold standard is open fragment excision or lateral release; however, arthroscopic management is also possible. Purpose: To investigate the safety and efficacy of arthroscopic treatment of painful bipartite patella. Study Design: Systematic review; Level of evidence, 4. Methods: Using Medline and Embase, we systematically reviewed the literature as of March 8, 2020, using the subject headings “bipartite patella” and “arthroscopy” and related key terms. All levels of evidence involving human studies in English were included. Articles were excluded if only the abstract was published or the study was related to nonsurgical treatment or nonrelated diagnoses. Data related to journal/article information, demographic/clinical data, arthroscopic technique, length of follow-up, treatment outcomes, and complications were extracted. Results: Eleven articles with 43 patients were included in the review. Most patients (n = 34; 79%) underwent arthroscopic lateral release, while 16% (n = 7) had arthroscopic excision of the accessory fragment and 5% (n = 2) had arthroscopic excision and release. All patients except for one, who experienced postoperative trauma, were pain-free after arthroscopic treatment and were able to return to sports after a mean 2.6 months. Conclusion: This review demonstrated that arthroscopic management of painful bipartite patella is a safe and effective alternative to open surgical excision or release. However, all articles were case studies or small case series, owing to the rarity of the condition. In the future, higher-level studies comparing arthroscopic techniques and postoperative rehabilitation programs should be performed.

Synovial chondromatosis of the temporomandibular joint and its management

Dental Update ◽  
2021 ◽  
Vol 48 (4) ◽  
pp. 285-286
Author(s):  
S Jannati ◽  
C Pretzl ◽  
N Ali ◽  
S Holmes
Keyword(s):  
Systematic Review ◽  
Connective Tissue ◽  
Temporomandibular Joint ◽  
Clinical Diagnosis ◽  
Synovial Membrane ◽  
Clinical Relevance ◽  
Synovial Chondromatosis ◽  
Subsynovial Connective Tissue ◽  
To Receive

Synovial chondromatosis is a condition in which loose fragments of cartilage develop in the synovial membrane of joints due to metaplasia of the subsynovial connective tissue. The resulting symptoms are similar to those of temporomandibular joint (TMJ) dysfunction. Clinical diagnosis can therefore be challenging. Synovial chondromatosis rarely occurs in the TMJ as its predilection is towards larger joints. A systematic review up until June 2010 reported a total 241 cases of TMJ synovial chondromatosis. We present two cases of TMJ synovial chondromatosis seen and treated in our department. CPD/Clinical Relevance: Awareness of TMJ synovial chondromatosis can enable patients to receive appropriate management before progression of the condition.

Arthroscopic management of synovial chondromatosis of the shoulder: a systematic review of literature

2020 ◽  
pp. 175857322097720
Author(s):  
J Patrick Park ◽  
Yousef Marwan ◽  
Saud M Alfayez ◽  
Mark L Burman ◽  
Paul A Martineau
Keyword(s):  
Systematic Review ◽  
Treatment Failure ◽  
Full Text ◽  
Disease Recurrence ◽  
Synovial Chondromatosis ◽  
Significant Heterogeneity ◽  
Review Of Literature ◽  
Female Ratio ◽  
Arthroscopic Management ◽  
The Mean

Background Synovial chondromatosis (SC) of the shoulder is rare, with limited literature on its management. This systematic review of literature aimed to characterize common arthroscopic techniques for the treatment of shoulder SC and patient outcomes. We hypothesized that arthroscopy is an effective operative modality for the management of shoulder SC. Methods PubMed and Embase databases were searched for articles on arthroscopic management of shoulder SC, published before 6 August 2020. All articles meeting inclusion criteria received an independent full-text review by two authors. Results An initial search found 64 articles. Following duplicate removal and title, abstract, and full-text reviews, 27 articles (48 patients) remained eligible. The mean age of patients was 33.0 years, with 2:1 male-to-female ratio. The mean follow-up was 41.8 months. SC was found to affect various intra- and extra-articular locations of the shoulder. Overall, arthroscopic treatment of shoulder SC was successful in 70.8%. Treatment failure was common in SC involving the bicipital tendon sheath. Disease recurrence was seen in 14.7%. Conclusion Literature on arthroscopic management of shoulder SC is limited, and significant heterogeneity in arthroscopic techniques was observed. Although arthroscopic management of shoulder SC is effective, further optimization is necessary to minimize treatment failure and disease recurrence.

Cannabis-associated arteritis

VASA ◽  
2010 ◽  
Vol 39 (1) ◽  
pp. 43-53 ◽  
Author(s):  
Grotenhermen
Keyword(s):  
Systematic Review ◽  
Case Reports ◽  
Case Series ◽  
Cardiovascular Effects ◽  
Causative Factor ◽  
Cannabis Use ◽  
Thromboangiitis Obliterans ◽  
Pathological Features ◽  
Scientific Support ◽  
Clinical And Pathological Features

Background: To investigate the hypothesis that cases of arteritis similar to thromboangiitis obliterans (TAO) and associated with the use of cannabis were caused by cannabis or THC (dronabinol), or that cannabis use is a co-factor of TAO. Patients and methods: A systematic review on case reports and the literature on so-called cannabis arteritis, TAO, and cardiovascular effects of cannabinoids was conducted. Results: Fifteen reports with 57 cases of an arteritis associated with the use of cannabis and two additional case series of TAO, in which some patients also used cannabis, were identified. Clinical and pathological features of cannabis-associated arteritis do not differ from TAO and the major risk factor of TAO, tobacco use, was present in most, if not in all of these cases. The proposed pathophysiological mechanisms for the development of an arteritis by cannabis use are not substantiated. Conclusions: The hypothesis of cannabis being a causative factor or co-factor of TAO or an arteritis similar to TAO is not supported by the available evidence. The use of the term “cannabis arteritis” should be avoided until or unless more convincing scientific support is forthcoming.

Dental Implant Placement in Patients with a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review

2020 ◽  
Author(s):  
Judd Sher ◽  
Kate Kirkham-Ali ◽  
Denny Luo ◽  
Catherine Miller ◽  
Dileep Sharma
Keyword(s):  
Systematic Review ◽  
At Risk ◽  
Drug Therapy ◽  
Dental Implant ◽  
Case Series ◽  
Cochrane Central Register ◽  
Bisphosphonate Treatment ◽  
Implant Placement ◽  
Increased Risk ◽  
History Of

The present systematic review evaluates the safety of placing dental implants in patients with a history of antiresorptive or antiangiogenic drug therapy. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were followed. PubMed, Cochrane Central Register of Controlled Trials, Scopus, Web of Science, and OpenGrey databases were used to search for clinical studies (English only) to July 16, 2019. Study quality was assessed regarding randomization, allocation sequence concealment, blinding, incomplete outcome data, selective outcome reporting, and other biases using a modified Newcastle-Ottawa scale and the Joanna Briggs Institute critical appraisal checklist for case series. A broad search strategy resulted in the identification of 7542 studies. There were 28 studies reporting on bisphosphonates (5 cohort, 6 case control, and 17 case series) and one study reporting on denosumab (case series) that met the inclusion criteria and were included in the qualitative synthesis. The quality assessment revealed an overall moderate quality of evidence among the studies. Results demonstrated that patients with a history of bisphosphonate treatment for osteoporosis are not at increased risk of implant failure in terms of osseointegration. However, all patients with a history of bisphosphonate treatment, whether taken orally for osteoporosis or intravenously for malignancy, appear to be at risk of ‘implant surgery-triggered’ MRONJ. In contrast, the risk of MRONJ in patients treated with denosumab for osteoporosis was found to be negligible. In conclusion, general and specialist dentists should exercise caution when planning dental implant therapy in patients with a history of bisphosphonate and denosumab drug therapy. Importantly, all patients with a history of bisphosphonates are at risk of MRONJ, necessitating this to be included in the informed consent obtained prior to implant placement. The James Cook University College of Medicine and Dentistry Honours program and the Australian Dental Research Foundation Colin Cormie Grant were the primary sources of funding for this systematic review.

Sign in / Sign up

Export Citation Format

Share Document